Cite
CARDIOVASCULAR SAFETY PROFILE OF CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITORS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF 17 RANDOMIZED CONTROLLED TRIALS.
MLA
Abdelaziz, Ahmed, et al. “Cardiovascular Safety Profile of Cholesteryl Ester Transfer Protein Inhibitors: A Systematic Review and Meta-Analysis of 17 Randomized Controlled Trials.” Journal of the American College of Cardiology (JACC), vol. 83, no. 13, Apr. 2024, p. 1950. EBSCOhost, https://doi.org/10.1016/S0735-1097(24)03940-8.
APA
Abdelaziz, A., Atta, K., Hafez, A., Abdellatif, M., Elaraby, A., Ibrahim, A. A., Ghaly, R., Suppah, M., Abdelaziz, M., Ali, S., & Abdelazeem, B. (2024). Cardiovascular Safety Profile of Cholesteryl Ester Transfer Protein Inhibitors: A Systematic Review and Meta-Analysis of 17 Randomized Controlled Trials. Journal of the American College of Cardiology (JACC), 83(13), 1950. https://doi.org/10.1016/S0735-1097(24)03940-8
Chicago
Abdelaziz, Ahmed, Karim Atta, Abdelrahman Hafez, Mohamed Abdellatif, Ahmed Elaraby, Ahmed A. Ibrahim, Ramy Ghaly, et al. 2024. “Cardiovascular Safety Profile of Cholesteryl Ester Transfer Protein Inhibitors: A Systematic Review and Meta-Analysis of 17 Randomized Controlled Trials.” Journal of the American College of Cardiology (JACC) 83 (13): 1950. doi:10.1016/S0735-1097(24)03940-8.